News about Global Pharma

Suven to Acquire Majority Stake in Sapala Organics

Suven Pharmaceuticals has signed a definitive agreement for a strategic controlling investment in Sapala Organics Private Ltd.

Global Pharma | 14/06/2024 | By Aishwarya |  715

Xeltis Bags IDE Approval from FDA for Initiation of US Pivotal Trial for aXess

Xeltis announces that it has gained approval from the US Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) submission to begin enrolling patients into a pivotal study for aXess.

Global Pharma | 13/06/2024 | By Manvi |  489

Prendio-BioProcure and Portal Innovations to Accelerate Life Science Innovation

Prendio-BioProcure has forged a strategic partnership with Portal Innovations, aimed at accelerating innovation and growth in the life science sector.

Global Pharma | 13/06/2024 | By Aishwarya |  568

Clario Announces FDA Clearance for its SpiroSphere with Wireless COR-12 ECG Device

This technological advancement allows for the consecutive collection of spirometry and ECG data during a single site visit through Clario's SpiroSphere® platform, consolidating all data into a single, unified database.

Global Pharma | 13/06/2024 | By Manvi |  696

Asahi Kasei Introduces Membrane System to Produce Water for Injection

Asahi Kasei has begun selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections.

Global Pharma | 13/06/2024 | By Aishwarya |  511

Lupin Signs License and Supply Deal with Fuji for Commercialization of Nextstellis

Lupin has signed a license and supply agreement with OLIC (Thailand) LTD. (OLIC), a subsidiary of the renowned Japanese pharmaceutical company Fuji Pharma Co., Ltd. (Fuji), for marketing Nextstellis (drospirenone and estetrol tablets) in Vietnam and Philippines.

Global Pharma | 13/06/2024 | By Aishwarya |  1855

Charles River Laboratories, MatTek Receive Grant from FCRI to Advance Research Alternatives

Charles River Laboratories International, Inc. has announced a multidisciplinary program, funded through a USD 1.3 million grant from the Foundation for Chemistry Research & Initiatives (FCRI), in coordination with ACC LRI, to develop a New Approach Methodology (NAM) inhalation toxicology test to reduce reliance on traditional animal research methods.

Global Pharma | 12/06/2024 | By Aishwarya |  766

FDA Grants IND Approval for Lomonitinib to Eilean Therapeutics

Eilean Therapeutics has announced that the US Food and Drug Administration (FDA) has cleared the IND for lomonitinib (ZE46-0134).

Global Pharma | 11/06/2024 | By Aishwarya |  516

Gland Pharma Appoints New Executive Chairman and CEO

Gland Pharma Ltd. has announced that Srinivas Sadu has been appointed as Executive Chairman and CEO of the company.

Global Pharma | 11/06/2024 | By Aishwarya |  1022

Calyx / Invicro Partners with BAMF Health to Boost Clinical Translation of RLT and IO Agents

Calyx / Invicro has announced a strategic partnership with BAMF Health, a world leader in molecular imaging and theranostics.

Global Pharma | 10/06/2024 | By Aishwarya |  583